127 related articles for article (PubMed ID: 25047914)
21. Peptide-tunable drug cytotoxicity via one-step assembled polymer nanoparticles.
Liang K; Richardson JJ; Ejima H; Such GK; Cui J; Caruso F
Adv Mater; 2014 Apr; 26(15):2398-402. PubMed ID: 24375889
[TBL] [Abstract][Full Text] [Related]
22. Exploration of the design principles of a cell-penetrating bicylic peptide scaffold.
Wallbrecher R; Depré L; Verdurmen WP; Bovée-Geurts PH; van Duinkerken RH; Zekveld MJ; Timmerman P; Brock R
Bioconjug Chem; 2014 May; 25(5):955-64. PubMed ID: 24697151
[TBL] [Abstract][Full Text] [Related]
23. Amphiphilic Cell-Penetrating Peptides Containing Arginine and Hydrophobic Residues as Protein Delivery Agents.
Moreno J; Zoghebi K; Salehi D; Kim L; Shoushtari SK; Tiwari RK; Parang K
Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986567
[TBL] [Abstract][Full Text] [Related]
24. Cyclic Peptide Containing Hydrophobic and Positively Charged Residues as a Drug Delivery System for Curcumin.
Shirazi AN; El-Sayed NS; Tiwari RK; Tavakoli K; Parang K
Curr Drug Deliv; 2016; 13(3):409-17. PubMed ID: 26511089
[TBL] [Abstract][Full Text] [Related]
25. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970
[TBL] [Abstract][Full Text] [Related]
26. Degradable and biocompatible nanoparticles decorated with cyclic RGD peptide for efficient drug delivery to hepatoma cells in vitro.
Loyer P; Bedhouche W; Huang ZW; Cammas-Marion S
Int J Pharm; 2013 Oct; 454(2):727-37. PubMed ID: 23747504
[TBL] [Abstract][Full Text] [Related]
27. Discovery of a Direct Ras Inhibitor by Screening a Combinatorial Library of Cell-Permeable Bicyclic Peptides.
Trinh TB; Upadhyaya P; Qian Z; Pei D
ACS Comb Sci; 2016 Jan; 18(1):75-85. PubMed ID: 26645887
[TBL] [Abstract][Full Text] [Related]
28. Heparosan based negatively charged nanocarrier for rapid intracellular drug delivery.
Chen JX; Liu W; Zhang M; Chen JH
Int J Pharm; 2014 Oct; 473(1-2):493-500. PubMed ID: 25089505
[TBL] [Abstract][Full Text] [Related]
29. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
Wen S; Liu H; Cai H; Shen M; Shi X
Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549
[TBL] [Abstract][Full Text] [Related]
30. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
[TBL] [Abstract][Full Text] [Related]
31. Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.
Zheng Z; Aojula H; Clarke D
J Drug Target; 2010 Jul; 18(6):477-87. PubMed ID: 20088680
[TBL] [Abstract][Full Text] [Related]
32. Assembled microcapsules by doxorubicin and polysaccharide as high effective anticancer drug carriers.
Du C; Zhao J; Fei J; Cui Y; Li J
Adv Healthc Mater; 2013 Sep; 2(9):1246-51. PubMed ID: 23554398
[TBL] [Abstract][Full Text] [Related]
33. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
[TBL] [Abstract][Full Text] [Related]
34. Targeted theranostic prodrugs based on an aggregation-induced emission (AIE) luminogen for real-time dual-drug tracking.
Yuan Y; Kwok RT; Zhang R; Tang BZ; Liu B
Chem Commun (Camb); 2014 Oct; 50(78):11465-8. PubMed ID: 25137179
[TBL] [Abstract][Full Text] [Related]
35. Multifunctional self-fluorescent polymer nanogels for label-free imaging and drug delivery.
Chen Y; Wilbon PA; Zhou J; Nagarkatti M; Wang C; Chu F; Tang C
Chem Commun (Camb); 2013 Jan; 49(3):297-9. PubMed ID: 23183550
[TBL] [Abstract][Full Text] [Related]
36. Enzyme-responsive multifunctional magnetic nanoparticles for tumor intracellular drug delivery and imaging.
Yang Y; Aw J; Chen K; Liu F; Padmanabhan P; Hou Y; Cheng Z; Xing B
Chem Asian J; 2011 Jun; 6(6):1381-9. PubMed ID: 21548100
[TBL] [Abstract][Full Text] [Related]
37. Design of a tumor-homing cell-penetrating peptide.
Myrberg H; Zhang L; Mäe M; Langel U
Bioconjug Chem; 2008 Jan; 19(1):70-5. PubMed ID: 18001077
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
39. Synergistic gene and drug tumor therapy using a chimeric peptide.
Han K; Chen S; Chen WH; Lei Q; Liu Y; Zhuo RX; Zhang XZ
Biomaterials; 2013 Jun; 34(19):4680-9. PubMed ID: 23537665
[TBL] [Abstract][Full Text] [Related]
40. Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells.
Li Y; Lei Y; Wagner E; Xie C; Lu W; Zhu J; Shen J; Wang J; Liu M
Bioconjug Chem; 2013 Jan; 24(1):133-43. PubMed ID: 23241015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]